Thioredoxin reductase 1 upregulates MCP-1 release in human endothelial cells

Biochemical and Biophysical Research Communications

Volumn 386, Issue 4, 2009, Pages 703-708

  Liu, Zhen Bo ^a   Shen, Xun ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Atherosclerosis; MCP 1; NF B; ROS; Thioredoxin reductase 1

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; THIOREDOXIN REDUCTASE 1; TRANSCRIPTION FACTOR RELA;

ARTICLE; ATHEROSCLEROSIS; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; ENDOTHELIUM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; TRANSCRIPTION INITIATION; UPREGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ATHEROSCLEROSIS; CELL NUCLEUS; CELLS, CULTURED; CHEMOKINE CCL2; ENDOTHELIUM, VASCULAR; HUMANS; REACTIVE OXYGEN SPECIES; THIOREDOXIN REDUCTASE 1; TRANSCRIPTION FACTOR RELA;

EID: 67650503673     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.06.100     Document Type: Article

References (23)

1. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
2. Charo I.F., and Taubman M.B. Chemokines in the pathogenesis of vascular disease. Circ. Res. 95 (2004) 858-866
3. Tedgui A., and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 86 (2006) 515-581
4. 2, and iron are required for TNF-{alpha}-induced MCP-1 gene expression in endothelial cells: role of Rac1 and NADPH oxidase. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H1001-H1007
5. Park H.S., Chun J.N., Jung H.Y., Choi C., and Bae Y.S. Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells. Cardiovasc. Res. 72 (2006) 447-455
6. Anema S.M., Walker S.W., Howie A.F., Arthur J.R., Nicol F., and Beckett G.J. Thioredoxin reductase is the major selenoprotein expressed in human umbilical-vein endothelial cells and is regulated by protein kinase C. Biochem. J. 342 (1999) 111-117
7. Holmgren A. Thioredoxin. Annu. Rev. Biochem. 54 (1985) 237-271
8. Takagi Y., Gon Y., Todaka T., Nozaki K., Nishiyama A., Sono H., Hashimoto N., Kikuchi H., and Yodoi J. Expression of thioredoxin is enhanced in atherosclerotic plaques and during neointima formation in rat arteries. Lab. Invest. 78 (1998) 957-966
9. Okuda M., Inoue N., Azumi H., Seno T., Sumi Y., Hirata K.-i., Kawashima S., Hayashi Y., Itoh H., Yodoi J., and Yokoyama M. Expression of glutaredoxin in human coronary arteries: its potential role in antioxidant protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1483-1487
10. Furman C., Rundlof A.K., Larigauderie G., Jaye M., Bricca G., Copin C., Kandoussi A.M., Fruchart J.C., Arner E.S.J., and Rouis M. Thioredoxin reductase 1 is upregulated in atherosclerotic plaques: specific induction of the promoter in human macrophages by oxidized low-density lipoproteins. Free Radic. Biol. Med. 37 (2004) 71-85
11. Nalvarte I., Damdimopoulos A.E., Nystom C., Nordman T., Miranda-Vizuete A., Olsson J.M., Eriksson L., Bjornstedt M., Arner E.S.J., and Spyrou G. Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells: effect on cell growth and differentiation. J. Biol. Chem. 279 (2004) 54510-54517
12. Edgell C.-J.S., McDonald C.C., and Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. USA 80 (1983) 3734-3737
13. Hill K.E., McCollum G.W., and Burk R.F. Determination of thioredoxin reductase activity in rat liver supernatant. Anal. Biochem. 253 (1997) 123-125
14. Seemann S., and Hainaut P. Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity. Oncogene 24 (2005) 3853-3863
15. Li W., Wang T., Ma C., Xiong T., Zhu Y., and Wang X. Calcitonin gene-related peptide inhibits interleukin-1beta-induced endogenous monocyte chemoattractant protein-1 secretion in type II alveolar epithelial cells. Am. J. Physiol. Cell Physiol. 291 (2006) C456-C465
16. Liu G.-H., Qu J., and Shen X. Thioredoxin-mediated negative autoregulation of peroxisome proliferator-activated receptor alpha transcriptional activity. Mol. Biol. Cell 17 (2006) 1822-1833
17. da Silva Correia J., Soldau K., Christen U., Tobias P.S., and Ulevitch R.J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. J. Biol. Chem. 276 (2001) 21129-21135
18. Zhao H., Joseph J., Fales H.M., Sokoloski E.A., Levine R.L., Vasquez-Vivar J., and Kalyanaraman B. Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. Proc. Natl. Acad. Sci. USA 102 (2005) 5727-5732
19. O'Donnell B.V., Tew D.G., Jones O.T., and England P.J. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem. J. 290 Pt. 1 (1993) 41-49
20. Martin T., Cardarelli P.M., Parry G.C., Felts K.A., and Cobb R.R. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur. J. Immunol. 27 (1997) 1091-1097
21. Arner E.S.J., and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267 (2000) 6102-6109
22. Nordberg J., and Arner E.S.J. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31 (2001) 1287-1312
23. Sakurai A., Yuasa K., Shoji Y., Himeno S., Tsujimoto M., Kunimoto M., Imura N., and Hara S. Overexpression of thioredoxin reductase I regulates NF-kappa B activation. J. Cell. Physiol. 198 (2004) 22-30